Cargando…
Tdp-43 cryptic exons are highly variable between cell types
BACKGROUND: TDP-43 proteinopathy is a prominent pathological feature that occurs in a number of human diseases including amyotrophic lateral sclerosis (ALS), frontotemporal dementia (FTD), and inclusion body myositis (IBM). Our recent finding that TDP-43 represses nonconserved cryptic exons led us t...
Autores principales: | Jeong, Yun Ha, Ling, Jonathan P., Lin, Sophie Z., Donde, Aneesh N., Braunstein, Kerstin E., Majounie, Elisa, Traynor, Bryan J., LaClair, Katherine D., Lloyd, Thomas E., Wong, Philip C. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5289002/ https://www.ncbi.nlm.nih.gov/pubmed/28153034 http://dx.doi.org/10.1186/s13024-016-0144-x |
Ejemplares similares
-
TDP-43 represses cryptic exon inclusion in the FTD–ALS gene UNC13A
por: Ma, X. Rosa, et al.
Publicado: (2022) -
A fluid biomarker reveals loss of TDP-43 splicing repression in pre-symptomatic ALS
por: Irwin, Katherine E., et al.
Publicado: (2023) -
TDP-43 maximizes nerve conduction velocity by repressing a cryptic exon for paranodal junction assembly in Schwann cells
por: Chang, Kae-Jiun, et al.
Publicado: (2021) -
Quantitative analysis of cryptic splicing associated with TDP-43 depletion
por: Humphrey, Jack, et al.
Publicado: (2017) -
Translation of the focus toward excellence in translational science: comment on “TDP-43 Repression of Nonconserved Cryptic Exons is Compromised in ALS-FTD”
por: Pochet, Roland, et al.
Publicado: (2015)